Spryte Medical Unveils Breakthrough Neuro Optical Coherence Tomography (nOCT) Technology
Spryte Medical has introduced groundbreaking neuro optical coherence tomography (nOCT) technology for patients with cerebrovascular disease.
Neuro Optical Coherence Tomography (nOCT) marks a significant advancement in neurointervention. Unlike traditional intravascular imaging systems primarily designed for cardiology, nOCT is specifically developed for cerebrovascular navigation.
This cutting-edge imaging technology allows for highly detailed visualisation of the brain's vascular anatomy at near-histologic levels, enhancing diagnostic capabilities and treatment precision.
Neurointervention has profoundly improved the treatment of cerebrovascular conditions, and nOCT intravascular imaging promises to further advance this field.
This technology enables better visualisation of diseases and devices, guides decision-making, and enhances patient care. OCT information could have a substantial impact on neurointervention outcomes, and there is excitement about bringing the benefits of this technology to the brain for the first time.
The initial clinical experience with nOCT has consistently demonstrated its ease of use, safety, and high imaging quality.
This nOCT technology is poised to revolutionise neurointervention, offering unmatched imaging quality, safety, and ease of use. By providing clinicians with detailed, real-time images of the brain’s vascular structures, nOCT aims to enable more precise interventions, potentially improving patient outcomes and advancing the understanding of cerebrovascular diseases.